311771-67-2

Upstream product

• 311770-87-3 benzyl 5-hydroxymethyl-2-methoxybenzoate 
• 311770-86-2 benzyl 5-formyl-2-methoxybenzoate 
• 100-39-0 benzyl bromide 
• 84923-70-6 5-formyl-2-methoxybenzoic acid 

Downstream Products

• 311771-69-4 [3(2S),4R]-3-[2-ethyl-3-[4-methoxy-3-(benzyloxycarbonyl)phenyl]propionyl]-4-benzyloxazolidin-2-one 
• 876296-13-8 (S)-2-(3-Aminomethyl-4-methoxy-benzyl)-butyric acid benzyl ester 
• 890928-74-2 (S)-2-(3-Bromomethyl-4-methoxy-benzyl)-butyric acid benzyl ester 
• 876296-12-7 (S)-2-(3-Hydroxymethyl-4-methoxy-benzyl)-butyric acid benzyl ester 
• 878268-40-7 2-[3-(tert-butyl-dimethyl-silanyloxymethyl)-4-methoxy-benzyl]-butyric acid benzyl ester 
• 878268-36-1 (S)-4-Benzyl-3-[(S)-2-(3-hydroxymethyl-4-methoxy-benzyl)-butyryl]-oxazolidin-2-one 
• 878268-34-9 5-[(S)-2-((S)-4-Benzyl-2-oxo-oxazolidine-3-carbonyl)-butyl]-2-methoxy-benzoic acid 
• 878268-45-2 (S)-2-[3-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-4-methoxy-benzyl]-butyric acid benzyl ester 
• 878268-38-3 (S)-4-Benzyl-3-{(S)-2-[3-(tert-butyl-dimethyl-silanyloxymethyl)-4-methoxy-benzyl]-butyryl}-oxazolidin-2-one 
• 876296-14-9 (S)-2-{3-[(2-Fluoro-4-trifluoromethyl-benzoylamino)-methyl]-4-methoxy-benzyl}-butyric acid benzyl ester 
• 876296-15-0 (S)-2-{3-[(3-Fluoro-4-trifluoromethyl-benzoylamino)-methyl]-4-methoxy-benzyl}-butyric acid benzyl ester 

Relevant academic research and scientific papers

Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR) α

The invention provides novel substituted phenylpropanoic acid derivatives that activate by binding to receptor as ligands of human peroxisome preliferant-activated receptor α (PPARα), and exhibit potent decreasing action on lipids in blood (cholesterol an

SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA(PPAR)

The invention provides novel substituted phenylpropanoic acid derivatives that activate by binding to receptor as ligands of human peroxisome preliferant-activated receptor α (PPARα), and exhibit potent decreasing action on lipids in blood (cholesterol and triglyceride). It relates to substituted phenylpropanoic acid derivatives represented by a general formula (1), their pharmaceutically acceptable salts and their hydrates, and processes for preparing them.